Portland, IN2 Active Studies

Peripheral Artery Disease Clinical Trials in Portland, IN

Find 2 actively recruiting peripheral artery disease clinical trials in Portland, IN. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
185
Enrolling

Recruiting Peripheral Artery Disease Studies in Portland

About Peripheral Artery Disease Clinical Trials in Portland

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 2 peripheral artery disease clinical trials recruiting participants in Portland, IN. These studies are seeking a combined 185 participants. Research is being sponsored by Philips Clinical & Medical Affairs Global, Oregon Health and Science University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Portland — FAQ

Are there peripheral artery disease clinical trials in Portland?

Yes, there are 2 peripheral artery disease clinical trials currently recruiting in Portland, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Portland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Portland research site will contact you about next steps.

Are clinical trials in Portland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Portland studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 2 active trials in Portland are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 13, 2026 from ClinicalTrials.gov